The UK’s Department for International Trade helps UK businesses export internationally, drives inward and outward investment, negotiates market access and trade deals, and champions free trade.
DIT Singapore at the British High Commission, works closely with Healthcare UK, a joint initiative between DIT, Department for Health and Social Care and NHS England, to develop international partnerships with Singapore in the following areas:
- Digital Health: Pioneering healthcare innovations in AI, VR and AR, IoT and remote monitoring, data analytics, app development, electronic health records, telehealth, telecare, health and wellbeing, laboratory and radiology information systems, business efficiencies, and other digital applications.
- Clinical Services: Cancer, Diabetes, Urgent and Emergency care, Fertility, Genomics, Elderly Care, Mental Health, Primary Care.
- Education & Training: UK knowledge and expertise delivered through multidisciplinary clinical E&T, leadership & management training and consultancy & advisory.
- Infrastructure Services: hospital design and builds, Public Private Partnerships (PPP), and project management
- Healthcare systems development: system best practice, clinical regulations and population wide prevention programmes
Standards and Interoperability Lab – Asia is a health interoperability lab that provides technical and capacity-building support to countries in making their healthcare systems and applications interoperable through foundational digital health frameworks, international standards, and emerging technologies (IHE, FHIR, Blockchain, etc.). The lab is established by the Asia eHealth Information Network, with support from the Asian Development Bank.
SIL-Asia supports the achievement and measurement of universal health coverage (UHC) through the use of information and communications technology (ICT). Making healthcare systems standards-based and interoperable is critical in integrating data and information at the level of the patient, the health facility, and the whole health sector. SIL-Asia believes that this will pave way for evidence-based decision making and thus, grounded health interventions that will contribute to good health and well-being of the citizenry.
Virtual Live Engagement Partner
Virtual Site Tour Partner
Asia Research News is an international research communications company specializing in the Asia-Pacific region. Founded in 2004, we work with researchers and institutions to communicate their discoveries to the wider world. We launched Asia’s first research news platform, creating a framework for institutions to share their news directly with readers and journalists. Our experienced team offers a complete suite of communication services and training for research institutions looking to expand their international presence. Asia Research News is proud to support Asia’s research community and increase awareness of the region’s innovation. Find out more at http://asiaresearchnews.com
Asia-Pacific Biotech News (APBN) is a monthly science and technology magazine published by World Scientific Publishing, one of the leading scientific publishers in the world. Our publication is available both in print and online. APBN’s readership reaches out to various professionals in the field those of which include scientists, researchers, industry experts and biotech investors. With the aim of bringing up – to – date news and advancements in science and technology within the Asia – Pacific region.
To create a community of informed readers, well-versed in the topics of science and technology and how it impacts the world around them.
To provide accurate, objective, and sincere reporting for research and industrial developments in the field of science and technology.
BioSpectrum Asia is the most influential source of information for life sciences industry and is uniquely positioned as a specialized B2B information platform in Asia Pacific region. The magazine provides comprehensive coverage and useful insights in the areas of pharmaceuticals, biotechnology, medical devices, research & development and policies.
Founded in Shanghai in 2002, GBI has built a diverse portfolio of market intelligence solutions for pharmaceutical and device companies and other service providers. Focused on China and the Latin American markets, GBI’s value-added industry information, news, and data services power individuals and organizations’ decision-making and enable more effective communication. As a trusted source of information, GBI has established long-term relationships with both multinational players and local firms, and continues to drive forward the health care industry.
GBI has offices in Shanghai, Beijing, and Washington D.C.
KONGPOSH Publications are one of the leading Pharma Publishers from INDIA.
The Pharma Review® is a bi-monthly article based journal. Contributions received from Eminent pharma personalities from India as well as other countries.
The journal has readership in many countries, provides media support to over 25 Pharma Expos and Conferences worldwide and has a large number of advertisers from India and overseas.
The journal is LISTED in Recommended Journals List of Pharmacy Council of INDIA for their approved Institutions. Abstracted & Indexed in International Pharmaceutical Abstract & Chemical Abstract & Listed Ulrich’s Database-USA, and Listed in Journals approved by UGC-INDIA.
On Line Link : www.kppub.com
Townscript (a BookMyShow Enterprise) is Asia’s leading event ticketing platform serving 300,000+ events in 27+ countries. Our clientele includes popular conference organisers like e27, EConsultancy, TEDx, TechSparks, BSides Singapore, The FIT Summit, APIdays, Kotlin Conf Jakarta, DevOps Days India & Jakarta, and more. BookMyShow also has an integration with Grab in Singapore.
We also launched Townscript Live: our own virtual events platform and a one-stop solution for virtual events. The platform allows you to manage registrations, payments and live-stream all in a single place. It offers affordable and secure streaming, unlike other video conferencing tools.